Eligibility criteria
Condition
Non Small Cell Lung Carcinoma
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- Advanced NSCLC
- Prior treatment with and failure of at least one regimen of chemotherapy and erlotinib
or gefitinib
- Prior treatment with no more than two chemotherapy regimens, including adjuvant
treatment
- Measurable disease
Exclusion criteria
Show details
- Chemotherapy, radiotherapy, biological or investigational agents within 4 weeks of
baseline disease assessment
- Patients who lack of tolerance of erlotinib therapy
- Patients with known brain Metastases
- Patients with demonstrated history of or presence of interstitial lung disease.